![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 04, 2007 11:04:25 AM
TTE is a development stage company and is publicly traded (TTEG.OB). It was formed to
support Alpha’s development efforts and commercialize its technology. Now that feasibility of
the technology has been demonstrated, it is transitioning from research and development to
commercialization of the technology.
TTE has several sustaining competitive advantages and barriers to entry. The technology was
patented in 1999, which provides a significant barrier to entry and years of intellectual property
protection. Alpha has developed trade secrets and significant expertise in the development of
turbine-based engines. In addition, the joint venture with CNF Transportation provides
significant access to the market and potential funding sources for rapid expansion and market
penetration.
TTE’s strategy over the next 2 years is to market its truck engines either through joint ventures
and or licensing agreements to established companies that have the capital resources to
commercialize there application in the trucking industry. After successfully demonstrating that
the engine works in field trials. TTE intends to raise another $20 million for acquisitions and
final stage testing with the engine in a highway trucks, with successful demonstrations TTE will
finalize the joint venture with CNF to manufacture our engines.
Strategic acquisitions will enable TTE to grow a profitable, complimentary business division that
in addition to providing a revenue stream will support engine development and testing.
Recent NVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:34 PM
- Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 06/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:30:13 PM
- Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million • Business Wire • 06/06/2024 07:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 07:00:19 PM
- Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products • Business Wire • 06/05/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 07:00:34 PM
- Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note • Business Wire • 06/03/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 01:00:14 PM
- Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program • Business Wire • 05/31/2024 01:00:00 PM
- Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 05/30/2024 08:30:00 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results • Business Wire • 04/15/2024 08:30:00 PM
- Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement • Business Wire • 04/11/2024 09:00:00 PM
- Novo Integrated Sciences Provides Update on Certain Current Actions and Events • Business Wire • 03/26/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:40 PM
- Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. • Business Wire • 02/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 07:00:19 PM
- Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note • Business Wire • 02/20/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 07:00:26 PM
- Novo Integrated Sciences Appoints New President • Business Wire • 02/16/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:00:20 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 05:00:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/22/2024 09:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:30:12 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results • Business Wire • 01/22/2024 09:30:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM